Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Elevated Triglycerides (Hypertriglyceridemia) Clinical Trials

A listing of Elevated Triglycerides (Hypertriglyceridemia) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (8) clinical trials

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Phase N/A

A Randomized, Double-Blind, Placebo-Controlled, with an Open Label Extension, Phase 2/3 Study of ISIS 304801 Administered Subcutaneously to Patients With Familial Partial Lipodystrophy

Phase N/A

At risk for heart conditions? Diabetes? High triglycerides? Global Medical Research is looking for individuals with cardiovascular issues and diabetes with high triglycerides for a clinical research study of an investigational medication.

Phase N/A

To access the efficacy, safety and tolerability of Gemcabene in subjects with severe hypertriglyceridemia.

Phase N/A

To evaluate the efficacy and safety of K-877 in subjects with fasting triglyceride levels ≥500mg/dL and <2000 mg/dL and normal renal function. Duration of study is 52 weeks on study drug.

Phase N/A

Comparing Tricor Avandia or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

It has been estimated that approximately ¼ of the US population has the Insulin Resistant Syndrome (IRS). The notion that insulin resistance and compensatory hyperinsulinemia lead to a cluster of abnormalities that increase CVD risk was first introduced in 1988, and central to the changes identified was a dyslipidemia characterized ...

Phase N/A

Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

Residual cardiovascular (CV) risk remains in dyslipidemic patients despite intensive statin therapy, underscoring the need for additional intervention. Eicosapentaenoic acid (EPA), an omega-3 polyunsaturated fatty acid, is incorporated into membrane phospholipids and atherosclerotic plaques and exerts beneficial effects on the pathophysiologic cascade from onset of plaque formation through rupture. EPA ...

Phase N/A

Hypertriglyceridaemia - Cause and Effects

Fats are present in the body in the form of lipid particles containing cholesterol and triglycerides. Lipid particles can deposit in blood vessels, forming atheromas, blocking blood vessels and leading to heart attacks and strokes. These harmful particles are termed 'atherogenic' particles. Low density lipoprotein (LDL) is the major atherogenic ...

Phase N/A